Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer

吴宇辰; 张长胜; 梁斐

doi:10.3969/j.issn.1007-3969.2015.07.006

您当前的位置：

首页 >

文章列表页 >

Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer

更新时间：2025-12-31

- Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer
- China Oncology Vol. 25, Issue 7, Pages: 522-528(2015)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院大肠外科，复旦大学上海医学院肿瘤学系,上海,200032
  2. 合肥市第二人民医院胃肠外科,安徽,合肥,230011
  3. 复旦大学附属肿瘤医院临床统计中心，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.07.006
  CLC：
- Published Online：09 December 2015，
  
  Published：09 December 2015
- 稿件说明：
移动端阅览
吴宇辰,张长胜,梁斐,等. 微卫星不稳定状态对Ⅳ期结直肠癌患者化疗反应性和预后的影响[J]. 中国癌症杂志, 2015, 25(7): 522-528.

吴宇辰, 张长胜, 梁斐. Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer[J]. China Oncology, 2015, 25(7): 522-528.
吴宇辰,张长胜,梁斐,等. 微卫星不稳定状态对Ⅳ期结直肠癌患者化疗反应性和预后的影响[J]. 中国癌症杂志, 2015, 25(7): 522-528. DOI： 10.3969/j.issn.1007-3969.2015.07.006.

吴宇辰, 张长胜, 梁斐. Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer[J]. China Oncology, 2015, 25(7): 522-528. DOI： 10.3969/j.issn.1007-3969.2015.07.006.

摘要

背景与目的：错配修复缺陷导致的微卫星不稳(microsatellite inistability，MSI)状态对Ⅱ、Ⅲ期结直肠癌患者的预后及化疗敏感性有重要作用，但在晚期肠癌中研究较少。该研究探讨微卫星不稳对晚期结直肠癌患者化疗敏感性及预后的影响。方法：收集采用XELOX或FOLFOX为一线化疗方案的Ⅳ期肠癌患者的原发肿瘤组织，免疫组化方法检测肿瘤组织中错配修复基因hMLH1、hMSH2、hMSH6和hPMS2的蛋白表达，分析微卫星状态与患者临床特征、预后及化疗反应的相关性。结果：共收集113例晚期结直肠癌患者，未发现MSI与患者总体生存时间(overall survival，OS)以及化疗敏感性存在相关。亚组分析中我们发现79例原发灶姑息性切除的患者中，MSI 患者(22例)较MSS患者(57例)的中位无疾病进展时间(progression-free survival，PFS)明显延长(19.9个月 vs 7个月，P=0.005)，但MSI与OS无关(P=0.07)。对该79例患者预后行Cox多因素分析显示，MSI是影响患者PFS的独立危险因素(P=0.043，MSS/MSI，HR=2.079)。此外，该群患者的MSI状态与疾病控制率(59.1% vs31.6%，P=0.025)相关。结论：在原发灶姑息性切除的Ⅳ期结直肠癌患者中，微卫星不稳定状态与无疾病进展时间和化疗的疾病控制率呈正相关，因而有必要对该群患者进行微卫星检测。

Abstract

Background and purpose: Microsatellite instability (MSI) status is commonly applied to predict the prognosis and chemosensitivity in stage Ⅱ and stage Ⅲ colorectal cancer patients. However

researches of its function on metastasis colorectal cancer are limited. This study investigated its value on prognosis and chemosensitivity in metastatic colorectal cancer (CRC) patients. Methods: We retrospectively investigated tumor tissues from metastasis CRC patients who were treated with oxaliplatin and 5-FU-based therapy regimens (FOLFOX and XELOX). Immunostaining of proteins of the mismatch repair gene hMLH1

hMSH2

hMSH6 and hPMS2 was performed. Prognostic value and chemosensitivity in patients with MSI status were also determined. Results: Clinical features from 113 patients were analyzed. No correlation of overall survival (OS) and chemosensitivity with MSI status was found. We further investigated 79 patients with synchronous metastasis and palliatively tumor resection. Median progression free survival (PFS) from 22 MSI patients was significant longer than that in 57 MSS patients (19.9 months vs 7 months

P=0.005). No significant difference was seen in OS comparison (P=0.07). MSI status was also an independent prognostic factors of PFS by Cox multivariate analysis (MSS/ MSI，HR=2.079

P=0.043). Moreover

in this group

MSI patients had improved disease control rate (59.1% vs 31.6%

P=0.025) in chemosensitivity analysis than MSS patients. Conclusion: A better PFS in MSI patients with synchronous metastasis and palliative tumor resection was found after treated with oxaliplatin and 5-FU-based therapy and a better chemosensitivity in MSI patients was also found.

关键词

Keywords

references

Views

2197

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

The application of Oncotype DX 21-gene assay in early-stage ER positive breast cancer

Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma

Prognosis of 51 patients with primary malignant melanomas of the cervix and vagina

Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis

Related Author

Sumei FAN

Congling XIN

Laifang ZHU

Chang LIU

Rui XU

Zhengrong ZHOU

Xi CHENG

章　颖

Related Institution

Department of Surgical Oncology, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Pharmacy, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Diagnostic Radiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Diagnostic Radiology, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Gynecological Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰